News
06-02-2016, 06:02 AM
New research funded by Breast Cancer Now has identified how the most common breast cancers could be using a cholesterol-based molecule to evade standard anti-hormone treatments, causing patients’ disease to return.
More... (http://www.news-medical.net/news/20160602/Scientists-reveal-how-ER2b-breast-cancer-uses-cholesterol-based-molecule-to-evade-anti-hormone-treatments.aspx)
More... (http://www.news-medical.net/news/20160602/Scientists-reveal-how-ER2b-breast-cancer-uses-cholesterol-based-molecule-to-evade-anti-hormone-treatments.aspx)